LOS ANGELES, Nov. 7, 2019 /PRNewswire/ -- A revolutionary robot can now detect lung cancer at an early stage allowing for more-accurate diagnosis, changing the prognosis for many now diagnosed with the #1 cancer killer worldwide for both men and women. Monarch™ Platform by Auris Health, Inc. has changed the medical detection landscape by viewing inside the lungs and obtaining a tissue sample for biopsy, enabling earlier and more-accurate analysis of small and hard-to-reach nodules in the periphery of the lung. Renowned Eisenhower Health in Rancho Mirage, California is one of the first in the U.S., and one of the first in Southern California to now offer this new innovative and state-of-the-art technology in the fight against lung cancer, the #1 cancer killer today.
Monarch™ Platform, recently cleared by the U.S. Food and Drug Administration (FDA), integrates the latest advancements in robotics, software, micro-instrumentation, sensing, data science and endoscopy into one platform to improve outcomes and reduce cost. This technology leverages the power of flexible robotics to enable new possibilities in endoscopy, using small cameras and tools to enter the body through its natural openings. It is intended for diagnostic and therapeutic bronchoscopic procedures.
"Lung cancer is now the leading cause of cancer deaths worldwide, in part because it has no symptoms in it's early stages. This provides improved reach, vision and control for bronchoscopic procedures and is a very important piece of technology that now provides physicians continuous bronchoscope vision throughout the procedure leading to earlier detection, better outcomes, and a more hopeful future for patients," says Justin Thomas, MD, Board Certified Internal Medicine, Pulmonary Disease and Critical Care Medicine and Director of the Bronchoscopy Laboratory at Eisenhower Health.
Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.
Lung cancer is #1 global leading cause of cancer-related deaths for both men and women according to the American Cancer Society
Although the disease is rare among those under the age of 45, more people die from lung cancer than from colon, breast and prostate cancers combined, for both smokers and non-smokers, however, the risks are much greater for smokers
More than 90% of people diagnosed with lung cancer do not survive, often due to detection at an advanced stage
A variety of diagnostic options are currently available for lung cancer but all have limitations in accuracy, safety, or invasiveness. Limitations can lead to false positives, false negatives, or side effects such as pneumothorax (collapsed lung) and hemorrhage, which may increase health care costs and extend hospital stays